The invention concerns 2-oxo- 1 -pyrrolidine derivatives of formula I, n n n n n n n n n n wherein the substituents are as defined in the specification, as well as their use as pharmaceuticals. n The compounds of the invention are particularly suited for treating neurological disorders such as epilepsy.